ESSILOR (EPA:EL) ESSILOR - Essilor Cancels Four Million Shares
Transparency directive : regulatory news
13/07/2010 06:30
Click here to download pdf version
News Release
Essilor Cancels Four Million Shares
Charenton-le-Pont, France (July 13, 2010 - 6:30 a.m.) - On June 28, 2010,
Essilor cancelled 4,000,000 shares, in line with its commitment not to create
any dilution for existing shareholders. The two-part transaction was carried out
as follows:
- 2,130,000 shares were cancelled to offset the dilutive impact of the vesting
of performance shares or the exercise of stock options granted to employees.
- 1,870,000 shares were cancelled to offset the dilution resulting from the
conversion of the now mature OCEANE convertible bonds. The shares had been
purchased as part of a program launched in 2008 to buy back up to 6,900,000
shares for allocation on conversion of the OCEANE bonds then outstanding. To
date, Essilor has bought back 5,200,000 shares under this program, of which
3,370,000 have now been cancelled.
Investor Relations and Financial Communications
Véronique Gillet - Sébastien Leroy
Phone: +33 (0)1 49 77 42 16
www.essilor.com
The world leader in ophthalmic optical products, Essilor International
researches, develops, manufactures and markets around the world a wide range of
lenses to improve and protect eyesight. Its flagship brands are Varilux(r),
Crizal(r), Essilor(r), Definity(r) and Xperio(TM).
Based in France, the company reported consolidated revenue of more than EUR3.2
billion in 2009, with 34,700 employees and operations in 100 countries.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the CAC 40 index.
Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.